Opin vísindi

Clinical indications of premenstrual disorders and subsequent risk of injury : a population-based cohort study in Sweden

Clinical indications of premenstrual disorders and subsequent risk of injury : a population-based cohort study in Sweden


Titill: Clinical indications of premenstrual disorders and subsequent risk of injury : a population-based cohort study in Sweden
Höfundur: Yang, Qian
Sjölander, Arvid
Li, Yuchen
Viktorin, Alexander
Bertone-Johnson, Elizabeth R.
Ye, Weimin
Fang, Fang
Valdimarsdóttir, Unnur A.
Lu, Donghao
Útgáfa: 2021-05-26
Tungumál: Enska
Umfang: 1409133
Deild: Faculty of Medicine
Birtist í: BMC Medicine; 19(1)
ISSN: 1741-7015
DOI: 10.1186/s12916-021-01989-4
Efnisorð: Slys; Fyrirtíðaspenna; Hóprannsóknir; Accidents; Cohort study; Injury; Premenstrual disorders; Suicidal behavior; Prospective Studies; Cross-Sectional Studies; Humans; Risk Factors; Female; Retrospective Studies; Sweden/epidemiology; Cohort Studies; General Medicine
URI: https://hdl.handle.net/20.500.11815/3102

Skoða fulla færslu

Tilvitnun:

Yang , Q , Sjölander , A , Li , Y , Viktorin , A , Bertone-Johnson , E R , Ye , W , Fang , F , Valdimarsdóttir , U A & Lu , D 2021 , ' Clinical indications of premenstrual disorders and subsequent risk of injury : a population-based cohort study in Sweden ' , BMC Medicine , vol. 19 , no. 1 , 119 , pp. 119 . https://doi.org/10.1186/s12916-021-01989-4

Útdráttur:

Background: Premenstrual disorders, including premenstrual syndrome and premenstrual dysphoric disorder, are suggested to be correlated with suicidal behavior and accidents in cross-sectional and retrospective studies. However, prospective data are still lacking. Methods: We performed a population-based cohort study including 1,472,379 Swedish women of reproductive age who were followed from 2001 to 2012. Within the cohort, we also performed a sibling analysis where we compared the rates of injury between full sisters. By linking to the Patient and the Prescribed Drug Registers, we identified 18,628 women with any clinical indications for premenstrual disorders in the cohort (population analysis) and 7674 women in the sibling analysis. Any injury, primarily suicidal behavior (completed suicide and suicide attempt) or accidents (e.g., fall and transportation accidents), was identified through the Patient and Causes of Death Registers as the primary outcome. We estimated hazard ratios (HRs) and 95% confidence intervals (CIs) of these outcomes among women with premenstrual disorders in both population and sibling analyses using multivariable Cox proportional hazards regression. Results: During a maximal follow-up of 12 years (mean 9.55 years), we identified 2390 women with premenstrual disorders with any injury; 216 through suicidal behavior and 2191 through accidents. Compared to women without premenstrual disorders, women with premenstrual disorders were at increased risk of any injury (HR 1.37, 95% CI 1.31–1.42), particularly suicidal behavior (HR 2.26, 95% CI 1.97–2.59) and accidents (HR 1.32, 95% CI 1.27–1.38). Such associations somewhat attenuated yet remained significant in the sibling analysis (HRs: 1.31 for any injury, 1.86 for suicidal behavior, and 1.29 for accidents). Additional adjustment for psychiatric comorbidities minimally altered the associations with any injury and accidents in both population and sibling analyses, whereas the association with suicidal behavior was considerably attenuated to non-significance in the sibling analysis. Such risks were particularly strong within 2 years after receiving the diagnosis of premenstrual disorders and were evident among women with premenstrual disorders with and without psychiatric comorbidities. Conclusions: Our findings suggest that women with a clinical indication of premenstrual disorders are at increased subsequent risk of injury, particularly accidents within the first 2 years after diagnosis.

Athugasemdir:

Funding Information: The work is supported by Erik and Edith Fernström Foundation (No. 2019-00415 to Dr. Yang), the Chinese Scholarship Council (No. 201700260289 to Dr. Yang), the Swedish Brain Foundation (Hjärnfonden) (to Dr. Viktorin), Grant of Excellence from the Icelandic Research Fund (No. 163362-051 and 218274-051 to Dr. Valdimarsdóttir), the Swedish Research Council for Health, Working Life and Welfare (FORTE) (No. 2020-00971 to Dr. Lu), and the Swedish Research Council (Vetenskapsrådet) (No. 2020-01003 to Dr. Lu). Researchers are independent of the funders. The funding has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. Open Access funding provided by Karolinska Institute. Publisher Copyright: © 2021, The Author(s).

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: